A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study (Q44704640)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2003

Language	Label	Description	Also known as
English	A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study	scientific article published in November 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

systolic hypertension

1 reference

based on heuristic

inferred from title

author name string

Ettore Malacco

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Natale Varì

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Vincenzo Capuano

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Vitaliano Spagnuolo

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Carlo Borgnino

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Paolo Palatini

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Val-Syst study

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

2765-2780

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive effects of valsartan/hydrochlorothiazide combination in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertensio

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Inadequate Management of Blood Pressure in a Hypertensive Population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Compliance with antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in antihypertensive therapy--the role of adverse effects and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerability of antihypertensive drugs in a community-based setting

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980332-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80332-6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44704640&oldid=2098835369"